Clinical Trial Update: Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pidotimod in children for recurrent respiratory tract infections has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Pidotimod

Snippet

Sponsor: Almirall, S.A. | Conditions: Recurrent Respiratory Tract Infections | Phase 4 | Status: COMPLETED